Skip to main content
U.K. Edition
Thursday, 3 April 2025

Semaglutide

Anti-diabetic and anti-obesity medication


Semaglutide
Semaglutide

Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold by Novo Nordisk under the brand names Ozempic and Rybelsus for diabetes, and under the brand name Wegovy for weight management and weight loss.

0 shares 2 views

News coverage

You might like